In the latest article from our neurosciences blog series, Karina D’Angelo sheds light on innovative real-world data strategies, including social determinants of health (#SDOH), that are improving diversity, participation, access, and, ultimately, patient outcomes in clinical trials. Read more: https://lnkd.in/ehrJkbcb #Alzheimers #RWD #RWE #ParexelBiotech
Naomi Angelotti’s Post
More Relevant Posts
-
In the latest article from our neurosciences blog series, Karina D’Angelo sheds light on innovative real-world data strategies, including social determinants of health (#SDOH), that are improving diversity, participation, access, and, ultimately, patient outcomes in clinical trials. Read more: https://lnkd.in/ehrJkbcb #Alzheimers #RWD #RWE #ParexelBiotech
To view or add a comment, sign in
-
In the latest article from our neurosciences blog series, Karina D’Angelo sheds light on innovative real-world data strategies, including social determinants of health (#SDOH), that are improving diversity, participation, access, and, ultimately, patient outcomes in clinical trials. Read more: https://lnkd.in/eRyRRcsT #Alzheimers #RWD #RWE #ParexelBiotech
To view or add a comment, sign in
-
In the latest article from our neurosciences blog series, Karina D’Angelo sheds light on innovative real-world data strategies, including social determinants of health (#SDOH), that are improving diversity, participation, access, and, ultimately, patient outcomes in clinical trials. Read more: https://lnkd.in/gxttKyCk #Alzheimers #RWD #RWE #ParexelBiotech
To view or add a comment, sign in
-
In the latest article from our neurosciences blog series, Karina D’Angelo sheds light on innovative real-world data strategies, including social determinants of health (#SDOH), that are improving diversity, participation, access, and, ultimately, patient outcomes in clinical trials. Read more: https://lnkd.in/eUViejVK #Alzheimers #RWD #RWE #ParexelBiotech
To view or add a comment, sign in
-
In the latest article from our neurosciences blog series, Karina D’Angelo sheds light on innovative real-world data strategies, including social determinants of health (#SDOH), that are improving diversity, participation, access, and, ultimately, patient outcomes in clinical trials. Read more: https://lnkd.in/e5fauPtt #Alzheimers #RWD #RWE #ParexelBiotech
To view or add a comment, sign in
-
In the latest article from our neurosciences blog series, Karina D’Angelo sheds light on innovative real-world data strategies, including social determinants of health (#SDOH), that are improving diversity, participation, access, and, ultimately, patient outcomes in clinical trials. Read more: #Alzheimers #RWD #RWE #ParexelBiotech
To view or add a comment, sign in
-
Including more underrepresented populations (URPs) in #AlzheimersDisease research is crucial for producing generalizable research findings and elucidating health disparities. For URPs, they exist in prevalence, incidence, clinical dementia features, postdiagnosis survival, neuropathological features, and biological and medical risk factors.¹,² Join the conversation at this year’s #AAIC24 #AlzheimersAwareness
To view or add a comment, sign in
-
Inspired by Acromegaly Awareness Day and want to help acromegaly patients get diagnosed sooner? Read on for an opportunity to participate in a study led by St. Michael’s Unity Health Toronto. ⤵️ We know that earlier diagnosis usually improves outcomes and quality of life. Please take part in our international research study that uses computer technology to try to diagnose patients sooner by detecting the earliest features of acromegaly. We are looking for individuals who currently have or previously had acromegaly (including gigantism) or other types of pituitary adenomas/tumours to participate. Your participation in this study is critical to help develop the most accurate tools for diagnosis and greatly improve the quality of life of future patients. In this study, you will be asked to upload your photographs and complete a questionnaire, for use in a machine learning analysis. You can access the study using the link provided below. If you have questions about taking part in this study, you can send an email to the research team at acromegaly-research@smh.ca or telephone at 001-416-864-5312. Thank you for considering participation in this project. For more information on the study or to participate, please click on the URL link below or enter it in your browser or scan the QR code: https://lnkd.in/gUsBYFFK #AcromegalyAwarenessDay #Acromegaly #Gigantism #Pituitary #RareDisease #AcromegalyResearch
To view or add a comment, sign in
-
With lead RST investigators Ikenna Ebuenyi and Julie Faieta, faculty at the Master of Rehabilitation Technology program at the University of Pittsburgh School of Health and Rehabilitation Sciences are investigating the use of rehabilitation in Alzheimer's Disease and Alzheimer's Disease Related Dementias, as well as factors that influence the practice and perspectives of stakeholders in the United States. Learn more about this project and others at the link below! https://loom.ly/ACqzjac #AssistiveTechnology #MRT H2P 💛💙
To view or add a comment, sign in
-
Do you want to help acromegaly patients get diagnosed sooner? Read on for an opportunity to participate in a study led by St. Michael’s Unity Health Toronto. ⤵️ We know that earlier diagnosis usually improves outcomes and quality of life. Please take part in our international research study that uses computer technology to try to diagnose patients sooner by detecting the earliest features of acromegaly. We are looking for individuals who currently have or previously had acromegaly (including gigantism) or other types of pituitary adenomas/tumours to participate. Your participation in this study is critical to help develop the most accurate tools for diagnosis and greatly improve the quality of life of future patients. In this study, you will be asked to upload your photographs and complete a questionnaire, for use in a machine learning analysis. You can access the study using the link provided below. If you have questions about taking part in this study, you can send an email to the research team at acromegaly-research@smh.ca or telephone at 001-416-864-5312. Thank you for considering participation in this project. For more information on the study or to participate, please click on the URL link below or enter it in your browser or scan the QR code: https://lnkd.in/gUsBYFFK #Acromegaly #Gigantism #Pituitary #RareDisease #AcromegalyResearch Unity Health Toronto
To view or add a comment, sign in